Explore more publications!

Wyoming Healthcare Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Healthcare Weekly.

Press releases published on December 31, 2025

XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
LuluTox Detox Tea Unveiled: Why Lulutox Tea Being Discussed as the Best Herbal Weight Loss Tea Blend for Women to Burn Fat in 2026
Alvotech Secures Term Loan Facility of USD 100 Million
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing
River Oaks Treatment Center Offers Expanded Mental Health Services as the New Year Brings Increased Focus on Wellness
Laguna Treatment Center Strengthens Clinical Team with New Behavioral Health Therapist
New Year, New Mission: Oxford Treatment Center Empowers Veterans to Reclaim Their Lives in 2026
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Valneva et le Serum Institute of India annoncent la fin de leur accord de licence pour le vaccin contre le chikungunya
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
BioNTX Marks the Close of the First Quarter of the 21st Century with Growth, Workforce Momentum, and Innovation Leadership
Clearmind Medicine Regains Compliance with Nasdaq Minimum Bid Price Requirement
Why Most New Year’s Resolutions Fail by January—And How to Make Them Stick in 2026
Intelligent Bio Solutions Announces New Manufacturing Partnership to Strengthen Global Production Capability and Increase Margins
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference
FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
Hydreight Technologies Enters the At-Home STI Testing Market With Exclusive Distribution and 50,000 Pre-Orders

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions